GenSpera announces plans to conduct public offering of equity units

H.C. Wainwright to help raise funds for clinical development of G-202

By Toni Weeks

San Luis Obispo, Calif., March 19 - GenSpera, Inc. plans to conduct a public offering of equity units, according to an S-1 filing with the Securities and Exchange Commission.

The company will sell common shares and warrants in the form of units. H.C. Wainwright & Co., LLC will be the agent.

Proceeds will be used for the clinical development of G-202 and general corporate purposes.

GenSpera is a San Antonio-based pharmaceutical company focused on the discovery and development of pro-drug cancer therapeutics.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.